Medtronic 2012 Annual Report Download - page 141

Download and view the complete annual report

Please find page 141 of the 2012 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 152

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152

PART IV
Item 15. Exhibits and Financial Statement Schedules
(a) 1. Financial Statement Schedules
Schedule II. Valuation and Qualifying Accounts years ended April 27, 2012, April 29, 2011, and April
30, 2010 (set forth on page 131 of this report).
All other schedules are omitted because they are not applicable or the required information is shown
in the financial statements or notes thereto.
2. Exhibits
Exhibit No. Description
3.1 Medtronic, Inc. Restated Articles of Incorporation, as amended (Exhibit 3.1).(p)
3.2 Medtronic, Inc. Bylaws, as amended to date (Exhibit 3.2).(b)
4.1 Medtronic, Inc. Specimen Common Stock Certificate
4.2 Indenture, dated as of September 11, 2001, between Medtronic, Inc. and Wells Fargo
Bank Minnesota, National Association. (Exhibit 4.2).(c)
4.3 Form of Indenture between Medtronic, Inc. and Wells Fargo Bank, National Association
(Exhibit 4.1).(e)
4.4 Indenture dated as of September 15, 2005 between Medtronic, Inc. and Wells Fargo
Bank, N. A., as Trustee, with respect to the 4.375% Senior Notes due 2010 and 4.750%
Senior Notes due 2015 (including the Forms of Notes thereof) (Exhibit 4.1).(f)
4.5 Form of 4.750% Senior Notes, Series B due September 15, 2015 (Exhibit 4.3).(f)
4.6 Indenture by and between Medtronic, Inc. and Wells Fargo Bank, N.A., as trustee dated
as of April 18, 2006 (including the Form of Convertible Senior Notes thereof) (Exhibit
4.1).(g)
4.7 Form of Indenture between Medtronic, Inc. and Wells Fargo Bank, National Association
(Exhibit 4.1).(t)
4.8 First Supplemental Indenture Dated March 12, 2009 between Medtronic, Inc. and Wells
Fargo Bank, National Association (including the Forms of Notes thereof) (Exhibit
4.1).(u)
4.9 Second Supplemental Indenture Dated March 16, 2010 between Medtronic, Inc. and
Wells Fargo Bank, National Association (including the Forms of Notes thereof) (Exhibit
4.1).(x)
4.10 Third Supplemental Indenture Dated March 15, 2011 between Medtronic, Inc. and Wells
Fargo Bank, National Association (including the Forms of Notes thereof) (Exhibit
4.1).(y)
4.11 Fourth Supplemental Indenture Dated March 19, 2012 between Medtronic, Inc. and
Wells Fargo Bank, National Association (including the Forms of Notes thereof) (Exhibit
4.2) (dd)
*10.1 1994 Stock Award Plan (amended and restated as of January 1, 2008) (Exhibit 10.1).(n)
*10.2 Medtronic Incentive Plan (amended and restated effective January 1, 2008) (Exhibit
*10.3 Medtronic, Inc. Executive Incentive Plan (Appendix C).(i)
124
10.2).(n)